Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
a significant loss in activity against Rpn11 is observed (IC50=77
US20130121954A1
STATs (STAT1 and STAT3) and NFκB p65 subunit
with attenuation of extrapituitary thyromimetic effects
BKI-1369 Catalog No.:M31153-C a significant loss in activityBKI 1369 is a bumped kinase inhibitor (BKI). BKI 1369 increases human Ether a go go related gene (hERG) inhibitory activity with an IC50 of 1. 52 M. BKI 1369 reduces the parasite burden and diseases severity in the gnotobiotic pig model. BKI 1369 has been well characterized for potency, stability, metabolism, toxicity, pharmacokinetics and is potent against C. parvum in infected mice and calves. Product information CAS Number: 1951431 22 3 Molecular
US$ 54.99
US$ 65.00
US$ 24.99
US$ 85.00
US$ 986.50
US$ 1739.00
US$ 15399.00
US$ 14700.00
US$ 39.99